FLT3 and acute myeloid leukemia: In the current study, we examined the characteristics and outcomes of R/R FLT3-ITD AML patients in a routine setting in order to evaluate the efficacy of standard treatments that appeared to have limited efficacy in the QUANTUM-R study.